Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer

Journal of Urology

Volumn 186, Issue 6, 2011, Pages 2221-2227

  Davies, Judson D ^a   Aghazadeh, Monty A ^a   Phillips, Sharon ^a   Salem, Shady ^a   Chang, Sam S ^a   Clark, Peter E ^a   Cookson, Michael S ^a   Davis, Rodney ^a   Herrell, S Duke ^a   Penson, David F ^a,b   Smith Jr , Joseph A ^a   Barocas, Daniel A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

biopsy; organ size; prostate; prostatic neoplasms; risk

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SIZE; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY;

COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK;

EID: 80755172262     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.07.104     Document Type: Article

References (21)

1. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
2. M.R. Cooperberg, D.P. Lubeck, and M.V. Meng The changing face of low-risk prostate cancer: trends in clinical presentation and primary management J Clin Oncol 22 2004 2141
3. A.V. D'Amico, A.A. Renshaw, and L. Arsenault Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy Int J Radiat Oncol Biol Phys 45 1999 841
4. F.K. Chun, T. Steuber, and A. Erbersdobler Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology Eur Urol 49 2006 820
5. T. Fukagai, T. Namiki, and H. Namiki Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens Pathol Int 51 2001 364
6. J.H. Pinthus, M. Witkos, and N.E. Fleshner Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome J Urol 176 2006 979
7. P.D. Sved, P. Gomez, and M. Manoharan Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer J Urol 172 2004 98
8. F. Dong, J.S. Jones, and A.J. Stephenson Prostate cancer volume at biopsy predicts clinically significant upgrading J Urol 179 2008 896
9. S.J. Freedland, C.J. Kane, and C.L. Amling Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications Urology 69 2007 495
10. M.R. Newton, S. Phillips, and S.S. Chang Smaller prostate size predicts high grade prostate cancer at final pathology J Urol 184 2010 930
11. J.I. Epstein, W.C. Allsbrook Jr, and M.B. Amin The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228
12. A. Rahmouni, A. Yang, and C.M. Tempany Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography J Comput Assist Tomogr 16 1992 935
13. S. Salem, S.S. Chang, and P.E. Clark Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence J Urol 184 2010 1334
14. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215
15. W. Kassouf, H. Nakanishi, and A. Ochiai Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies J Urol 178 2007 111
16. G. Andriole, D. Bostwick, and F. Civantos The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge J Urol 174 2005 2098
17. S.J. Freedland, W.B. Isaacs, and E.A. Platz Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study J Clin Oncol 23 2005 7546
18. R.S. Turley, R.J. Hamilton, and M.K. Terris Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database J Urol 179 2008 523
19. P.M. Pierorazio, M.D. Kinnaman, and M.S. Wosnitzer Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy Urology 70 2007 696
20. G.S. Kulkarni, R. Al-Azab, and G. Lockwood Evidence for a biopsy derived grade artifact among larger prostate glands J Urol 175 2006 505
21. G.S. Kulkarni, G. Lockwood, and A. Evans Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy Cancer 109 2007 2432